semaglutide injection manufacturer in india title Today we launch, Obeda®, India's first DCGI-approved generic for Type 2 Diabetes. This product reinforces our purpose of good health cant wait, to bring high quality and affordable treatment India floods market with low-cost
Pay in 4 interest-free payments of $5.95 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
























